GSDMD is the last downstream substrate of the pyroptosis pathway and has the closest relationship with pyroptotic cell death; therefore, targeted inhibition of GSDMD may be a viable option for the treatment of stroke (Fig. 4) [88]. Here, GSDMD is linked to Stroke.